High Prevalence of Cancer and Approval and Launch of Signal MRI Markers Brachytherapy Market
Brachytherapy, the name given to the treatment of cancer using radiation has been around since the 1970's when it was discovered that patients who had high levels of melatonin in their blood showed an increased rate of response to radiation. The theory behind this phenomenon was that the patient's body was producing an excess of the hormone. The theory was that this hormone was responsible for the patient's sensitivity to radiation. Brachytherapy is essentially the same procedure but instead of radiation being applied to the affected area, it is applied to the skin. Instead of being applied to the skin, it is often applied directly to the tissue of the internal organs in order to achieve better results.
Market Dynamics
High prevalence of cancer is expected to propel the growth of the brachytherapy market.
For instance, according to the American Cancer Society, in 2019, there will be
an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in
the U.S. Moreover, increasing adoption of adaptive breast brachytherapy
treatment is also expected to aid in the growth of the market. For instance, in August
2020, Advanced Radiation Therapy, LLC completed the installation of the
AccuBoost Digital platform at the Central Florida Cancer Institute, U.S.
Approval
and launch of signal MRI markers is expected to offer lucrative growth
opportunities for players in the brachytherapy market. For instance in January
2021, C4 Imaging, a developer of medical devices, received FDA 510(k) clearance
for Sirius Positive Signal MRI Marker for use with Isoray’s Cesium-131. Moreover,
adoption of machine learning in brachytherapy is also expected to aid in growth
of the market. For instance, in October 2020, RaySearch Laboratories AB, a Sweden-based
medical technology company that develops software used in radiation therapy of
cancer, announced to present further advances in machine learning and support
for brachytherapy at ASTRO 2020.
Among
regions, North America is expected to witness significant growth in the brachytherapy
market, owing to launch of new products in the region. For instance, in June
2019, Isoray, Inc. announced to launch The Power of Blu campaign introducing a
new look and feel for the Cesium product group at the American Brachytherapy
Society’s annual meeting.
Competitive Analysis
Major
players operating in the brachytherapy market include, Elekta, Varian Medical
Systems, Inc., Theragenics Corporation, Sun Nuclear Corporation, Argon Medical
Devices, Eckert & Ziegler BEBIG, IsoRay Medical, Cianna Medical, iCAD Inc.,
and CIVCO Medical Solutions.
Major
players operating in the brachytherapy market are focused on launching new
products to expand their product portfolio. For instance, in November 2020, Elekta
introduced Elekta Studio with its launch of the ImagingRing, an advanced
interventional CT system that revolves around the patient and enables
clinicians to conduct the entire brachytherapy workflow.
Comments
Post a Comment